This research report focuses on the Aesthetic Injectables Market. It analyzes market size, trends and demand forecasts, as well as growth factors and challenges. The report provides market data breakdowns by type, application, company, and region, in addition to competitive landscape and key company profiles.
TABLE OF CONTENTS
1 Study Coverage
- 1.1 Aesthetic Injectables Product Introduction
- 1.2 Market by Type
- 1.2.1 Global Aesthetic Injectables Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
- 1.2.2 Sunken Cheeks or Temples
- 1.2.3 Reducing Lines Around Nose and Mouth (marionette Lines and Smile Lines)
- 1.2.4 Plumping Up Lips
- 1.2.5 Enhancing Facial Contour
- 1.3 Market by Application
- 1.3.1 Global Aesthetic Injectables Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
- 1.3.2 Hospital
- 1.3.3 Beauty Clinic
- 1.4 Assumptions and Limitations
- 1.5 Study Objectives
- 1.6 Years Considered
2 Executive Summary
- 2.1 Global Aesthetic Injectables Sales Estimates and Forecasts 2018-2029
- 2.2 Global Aesthetic Injectables Revenue by Region
- 2.2.1 Global Aesthetic Injectables Revenue by Region: 2018 VS 2022 VS 2029
- 2.2.2 Global Aesthetic Injectables Revenue by Region (2018-2023)
- 2.2.3 Global Aesthetic Injectables Revenue by Region (2024-2029)
- 2.2.4 Global Aesthetic Injectables Revenue Market Share by Region (2018-2029)
- 2.3 Global Aesthetic Injectables Sales Estimates and Forecasts 2018-2029
- 2.4 Global Aesthetic Injectables Sales by Region
- 2.4.1 Global Aesthetic Injectables Sales by Region: 2018 VS 2022 VS 2029
- 2.4.2 Global Aesthetic Injectables Sales by Region (2018-2023)
- 2.4.3 Global Aesthetic Injectables Sales by Region (2024-2029)
- 2.4.4 Global Aesthetic Injectables Sales Market Share by Region (2018-2029)
- 2.5 US & Canada
- 2.6 Europe
- 2.7 China
- 2.8 Asia (excluding China)
- 2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
- 3.1 Global Aesthetic Injectables Sales by Manufacturers
- 3.1.1 Global Aesthetic Injectables Sales by Manufacturers (2018-2023)
- 3.1.2 Global Aesthetic Injectables Sales Market Share by Manufacturers (2018-2023)
- 3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Aesthetic Injectables in 2022
- 3.2 Global Aesthetic Injectables Revenue by Manufacturers
- 3.2.1 Global Aesthetic Injectables Revenue by Manufacturers (2018-2023)
- 3.2.2 Global Aesthetic Injectables Revenue Market Share by Manufacturers (2018-2023)
- 3.2.3 Global Top 10 and Top 5 Companies by Aesthetic Injectables Revenue in 2022
- 3.3 Global Key Players of Aesthetic Injectables, Industry Ranking, 2021 VS 2022 VS 2023
- 3.4 Global Aesthetic Injectables Sales Price by Manufacturers
- 3.5 Analysis of Competitive Landscape
- 3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
- 3.5.2 Global Aesthetic Injectables Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
- 3.6 Global Key Manufacturers of Aesthetic Injectables, Manufacturing Base Distribution and Headquarters
- 3.7 Global Key Manufacturers of Aesthetic Injectables, Product Offered and Application
- 3.8 Global Key Manufacturers of Aesthetic Injectables, Date of Enter into This Industry
- 3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
- 4.1 Global Aesthetic Injectables Sales by Type
- 4.1.1 Global Aesthetic Injectables Historical Sales by Type (2018-2023)
- 4.1.2 Global Aesthetic Injectables Forecasted Sales by Type (2024-2029)
- 4.1.3 Global Aesthetic Injectables Sales Market Share by Type (2018-2029)
- 4.2 Global Aesthetic Injectables Revenue by Type
- 4.2.1 Global Aesthetic Injectables Historical Revenue by Type (2018-2023)
- 4.2.2 Global Aesthetic Injectables Forecasted Revenue by Type (2024-2029)
- 4.2.3 Global Aesthetic Injectables Revenue Market Share by Type (2018-2029)
- 4.3 Global Aesthetic Injectables Price by Type
- 4.3.1 Global Aesthetic Injectables Price by Type (2018-2023)
- 4.3.2 Global Aesthetic Injectables Price Forecast by Type (2024-2029)
5 Market Size by Application
- 5.1 Global Aesthetic Injectables Sales by Application
- 5.1.1 Global Aesthetic Injectables Historical Sales by Application (2018-2023)
- 5.1.2 Global Aesthetic Injectables Forecasted Sales by Application (2024-2029)
- 5.1.3 Global Aesthetic Injectables Sales Market Share by Application (2018-2029)
- 5.2 Global Aesthetic Injectables Revenue by Application
- 5.2.1 Global Aesthetic Injectables Historical Revenue by Application (2018-2023)
- 5.2.2 Global Aesthetic Injectables Forecasted Revenue by Application (2024-2029)
- 5.2.3 Global Aesthetic Injectables Revenue Market Share by Application (2018-2029)
- 5.3 Global Aesthetic Injectables Price by Application
- 5.3.1 Global Aesthetic Injectables Price by Application (2018-2023)
- 5.3.2 Global Aesthetic Injectables Price Forecast by Application (2024-2029)
6 US & Canada
- 6.1 US & Canada Aesthetic Injectables Market Size by Type
- 6.1.1 US & Canada Aesthetic Injectables Sales by Type (2018-2029)
- 6.1.2 US & Canada Aesthetic Injectables Revenue by Type (2018-2029)
- 6.2 US & Canada Aesthetic Injectables Market Size by Application
- 6.2.1 US & Canada Aesthetic Injectables Sales by Application (2018-2029)
- 6.2.2 US & Canada Aesthetic Injectables Revenue by Application (2018-2029)
- 6.3 US & Canada Aesthetic Injectables Market Size by Country
- 6.3.1 US & Canada Aesthetic Injectables Revenue by Country: 2018 VS 2022 VS 2029
- 6.3.2 US & Canada Aesthetic Injectables Sales by Country (2018-2029)
- 6.3.3 US & Canada Aesthetic Injectables Revenue by Country (2018-2029)
- 6.3.4 US
- 6.3.5 Canada
7 Europe
- 7.1 Europe Aesthetic Injectables Market Size by Type
- 7.1.1 Europe Aesthetic Injectables Sales by Type (2018-2029)
- 7.1.2 Europe Aesthetic Injectables Revenue by Type (2018-2029)
- 7.2 Europe Aesthetic Injectables Market Size by Application
- 7.2.1 Europe Aesthetic Injectables Sales by Application (2018-2029)
- 7.2.2 Europe Aesthetic Injectables Revenue by Application (2018-2029)
- 7.3 Europe Aesthetic Injectables Market Size by Country
- 7.3.1 Europe Aesthetic Injectables Revenue by Country: 2018 VS 2022 VS 2029
- 7.3.2 Europe Aesthetic Injectables Sales by Country (2018-2029)
- 7.3.3 Europe Aesthetic Injectables Revenue by Country (2018-2029)
- 7.3.4 Germany
- 7.3.5 France
- 7.3.6 U.K.
- 7.3.7 Italy
- 7.3.8 Russia
8 China
- 8.1 China Aesthetic Injectables Market Size
- 8.1.1 China Aesthetic Injectables Sales (2018-2029)
- 8.1.2 China Aesthetic Injectables Revenue (2018-2029)
- 8.2 China Aesthetic Injectables Market Size by Application
- 8.2.1 China Aesthetic Injectables Sales by Application (2018-2029)
- 8.2.2 China Aesthetic Injectables Revenue by Application (2018-2029)
9 Asia (excluding China)
- 9.1 Asia Aesthetic Injectables Market Size by Type
- 9.1.1 Asia Aesthetic Injectables Sales by Type (2018-2029)
- 9.1.2 Asia Aesthetic Injectables Revenue by Type (2018-2029)
- 9.2 Asia Aesthetic Injectables Market Size by Application
- 9.2.1 Asia Aesthetic Injectables Sales by Application (2018-2029)
- 9.2.2 Asia Aesthetic Injectables Revenue by Application (2018-2029)
- 9.3 Asia Aesthetic Injectables Sales by Region
- 9.3.1 Asia Aesthetic Injectables Revenue by Region: 2018 VS 2022 VS 2029
- 9.3.2 Asia Aesthetic Injectables Revenue by Region (2018-2029)
- 9.3.3 Asia Aesthetic Injectables Sales by Region (2018-2029)
- 9.3.4 Japan
- 9.3.5 South Korea
- 9.3.6 China Taiwan
- 9.3.7 Southeast Asia
- 9.3.8 India
10 Middle East, Africa and Latin America
- 10.1 Middle East, Africa and Latin America Aesthetic Injectables Market Size by Type
- 10.1.1 Middle East, Africa and Latin America Aesthetic Injectables Sales by Type (2018-2029)
- 10.1.2 Middle East, Africa and Latin America Aesthetic Injectables Revenue by Type (2018-2029)
- 10.2 Middle East, Africa and Latin America Aesthetic Injectables Market Size by Application
- 10.2.1 Middle East, Africa and Latin America Aesthetic Injectables Sales by Application (2018-2029)
- 10.2.2 Middle East, Africa and Latin America Aesthetic Injectables Revenue by Application (2018-2029)
- 10.3 Middle East, Africa and Latin America Aesthetic Injectables Sales by Country
- 10.3.1 Middle East, Africa and Latin America Aesthetic Injectables Revenue by Country: 2018 VS 2022 VS 2029
- 10.3.2 Middle East, Africa and Latin America Aesthetic Injectables Revenue by Country (2018-2029)
- 10.3.3 Middle East, Africa and Latin America Aesthetic Injectables Sales by Country (2018-2029)
- 10.3.4 Brazil
- 10.3.5 Mexico
- 10.3.6 Turkey
- 10.3.7 Israel
- 10.3.8 GCC Countries
11 Company Profiles
- 11.1 Allergan Plc
- 11.1.1 Allergan Plc Company Information
- 11.1.2 Allergan Plc Overview
- 11.1.3 Allergan Plc Aesthetic Injectables Sales, Price, Revenue and Gross Margin (2018-2023)
- 11.1.4 Allergan Plc Aesthetic Injectables Product Model Numbers, Pictures, Descriptions and Specifications
- 11.1.5 Allergan Plc Recent Developments
- 11.2 Galderma SA
- 11.2.1 Galderma SA Company Information
- 11.2.2 Galderma SA Overview
- 11.2.3 Galderma SA Aesthetic Injectables Sales, Price, Revenue and Gross Margin (2018-2023)
- 11.2.4 Galderma SA Aesthetic Injectables Product Model Numbers, Pictures, Descriptions and Specifications
- 11.2.5 Galderma SA Recent Developments
- 11.3 Merz Pharma GmbH & Co KgaA
- 11.3.1 Merz Pharma GmbH & Co KgaA Company Information
- 11.3.2 Merz Pharma GmbH & Co KgaA Overview
- 11.3.3 Merz Pharma GmbH & Co KgaA Aesthetic Injectables Sales, Price, Revenue and Gross Margin (2018-2023)
- 11.3.4 Merz Pharma GmbH & Co KgaA Aesthetic Injectables Product Model Numbers, Pictures, Descriptions and Specifications
- 11.3.5 Merz Pharma GmbH & Co KgaA Recent Developments
- 11.4 Sinclair Pharma Plc
- 11.4.1 Sinclair Pharma Plc Company Information
- 11.4.2 Sinclair Pharma Plc Overview
- 11.4.3 Sinclair Pharma Plc Aesthetic Injectables Sales, Price, Revenue and Gross Margin (2018-2023)
- 11.4.4 Sinclair Pharma Plc Aesthetic Injectables Product Model Numbers, Pictures, Descriptions and Specifications
- 11.4.5 Sinclair Pharma Plc Recent Developments
- 11.5 Teoxane SA
- 11.5.1 Teoxane SA Company Information
- 11.5.2 Teoxane SA Overview
- 11.5.3 Teoxane SA Aesthetic Injectables Sales, Price, Revenue and Gross Margin (2018-2023)
- 11.5.4 Teoxane SA Aesthetic Injectables Product Model Numbers, Pictures, Descriptions and Specifications
- 11.5.5 Teoxane SA Recent Developments
- 11.6 Bohus BioTech AB
- 11.6.1 Bohus BioTech AB Company Information
- 11.6.2 Bohus BioTech AB Overview
- 11.6.3 Bohus BioTech AB Aesthetic Injectables Sales, Price, Revenue and Gross Margin (2018-2023)
- 11.6.4 Bohus BioTech AB Aesthetic Injectables Product Model Numbers, Pictures, Descriptions and Specifications
- 11.6.5 Bohus BioTech AB Recent Developments
- 11.7 AbbVie Inc
- 11.7.1 AbbVie Inc Company Information
- 11.7.2 AbbVie Inc Overview
- 11.7.3 AbbVie Inc Aesthetic Injectables Sales, Price, Revenue and Gross Margin (2018-2023)
- 11.7.4 AbbVie Inc Aesthetic Injectables Product Model Numbers, Pictures, Descriptions and Specifications
- 11.7.5 AbbVie Inc Recent Developments
- 11.8 Huadong Medicine Co., Ltd
- 11.8.1 Huadong Medicine Co., Ltd Company Information
- 11.8.2 Huadong Medicine Co., Ltd Overview
- 11.8.3 Huadong Medicine Co., Ltd Aesthetic Injectables Sales, Price, Revenue and Gross Margin (2018-2023)
- 11.8.4 Huadong Medicine Co., Ltd Aesthetic Injectables Product Model Numbers, Pictures, Descriptions and Specifications
- 11.8.5 Huadong Medicine Co., Ltd Recent Developments
12 Industry Chain and Sales Channels Analysis
- 12.1 Aesthetic Injectables Industry Chain Analysis
- 12.2 Aesthetic Injectables Key Raw Materials
- 12.2.1 Key Raw Materials
- 12.2.2 Raw Materials Key Suppliers
- 12.3 Aesthetic Injectables Production Mode & Process
- 12.4 Aesthetic Injectables Sales and Marketing
- 12.4.1 Aesthetic Injectables Sales Channels
- 12.4.2 Aesthetic Injectables Distributors
- 12.5 Aesthetic Injectables Customers
13 Market Dynamics
- 13.1 Aesthetic Injectables Industry Trends
- 13.2 Aesthetic Injectables Market Drivers
- 13.3 Aesthetic Injectables Market Challenges
- 13.4 Aesthetic Injectables Market Restraints
14 Key Findings in The Global Aesthetic Injectables Study
15 Appendix
- 15.1 Research Methodology
- 15.1.1 Methodology/Research Approach
- 15.1.2 Data Source
- 15.2 Author Details
- 15.3 Disclaimer